Google’s new tool will identify skin conditions what will people do with that information?
There’s little research on what people do after they use a symptom-checker
Share this story
Image: Google
Google announced last Tuesday that it developed a new artificial intelligence tool to help people identify skin conditions. Like any other symptom-checking tool, it’ll face questions over how accurately it can perform that task. But experts say it should also be scrutinized for how it influences people’s behavior: does it make them more likely to go to the doctor? Less likely?
These types of symptom-checking tools which usually clarify that they can’t diagnose health conditions but can give people a read on what might be wrong have proliferated over the past decade. Some have millions of users and are valued at tens of millions of dollars. Dozens popped up over the past year to help people check to see if they might have COVID-19 (including one by Google).
Research Article
The sugar content of foods in the UK by category and company: A repeated cross-sectional study, 2015-2018
Lauren K. Bandy , Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Visualization, Writing – original draft, Writing – review & editing
Affiliation Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
Affiliation Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
Affiliation Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
Affiliation Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom ⨯
The sugar content of foods in the UK by category and company: A repeated cross-sectional study, 2015-2018
A new drug combination that is better at treating miscarriage is also more cost effective than current standard NHS treatment, finds a new study led by the University of Birmingham and Tommy’s National Centre for Miscarriage Research.A previous study
E-Mail
A new drug combination that is better at treating miscarriage is also more cost effective than current standard NHS treatment, finds a new study led by the University of Birmingham and Tommy s National Centre for Miscarriage Research.
A previous study by the same team and published in The Lancet in August last year, found that a combined drug treatment is more effective than the standard medication for women having miscarriages without symptoms - also known as missed, delayed or silent miscarriage.
Missed miscarriage occurs when a baby has died in the womb but the mother hasn t had symptoms, such as bleeding or pain. Current hospital restrictions on surgery mean that many women face waiting for the miscarriage to happen by itself, which can take weeks and still might not happen, or being offered medication to speed the process along.